A cyclin-dependent kinase (cdk) inhibitor, p27 Kip1 (p27), binds to the cyclin E-cdk2 complex and functions as a suppressor of cell cycle promotion. Here, the involvement of p27 in the growth of normal human endometrium was immunohistochemically studied, and the findings were compared with those of Ki-67, cyclin E and cdk2. In addition, to elucidate the effect of progesterone on the expression of p27, tissues from patients with endometrial hyperplasia were examined before and after the administration of medroxyprogesterone acetate (MPA) for the treatment of this disease. In the glandular cells of the normal endometrium, p27 was negligible during the proliferative phase, whereas it was markedly increased in the secretory phase. The staining pattern of Ki-67 was the reverse. Cyclin E/cdk2-positive cells were observed throughout the menstrual cycle. In the secretory phase, the cyclin E/cdk2-positive cells were also positive for p27, suggesting an interaction between these molecules. Stromal cells, especially in the basalis, showed a consistent expression of p27 throughout the menstrual cycle. The expression of p27 in hyperplastic epithelia before the MPA treatment was negligible, whereas it was greatly increased after the treatment. The Ki-67 positivity decreased after the treatment. These findings suggest that p27 is involved in the progesterone-induced growth suppression of normal and hyperplastic endometria.
Introduction
The proliferation and differentiation of human endometrium are controlled by ovarian steroids via their receptors. Oestrogen stimulates the proliferation of both glandular cells and stromal cells, whereas progesterone inhibits the growth of glandular cells, and induces secretory and decidual changes in glandular and stromal cells respectively (Strauss and Gurpide, 1991) . Although the progesterone-induced growth suppression of endometrial epithelia has been explained in various ways such as via the down-regulation of oestrogen receptors (Levy et al., 1980; Lessey et al., 1988) , the elevated function of steroid metabolizing enzymes (Tseng and Mazzella, 1980) and growth factors and cytokines (Giudice, 1994) , the molecular mechanisms which negatively regulate the growth of endometrial cells are not fully understood.
Advances in cell cycle research have revealed that cell proliferation is regulated by the interaction between cyclins/ cyclin-dependent kinases (cdk) and tumour suppressor gene products such as the retinoblastoma gene product (pRb) and cdk inhibitors (Nurse, 1994; Sherr, 1994; Sherr and Roberts, 1995) . The cyclin/cdk complexes inactivate pRb, leading to cell cycle progression. Conversely, the cyclin/cdk complexes are inactivated by cdk inhibitors, resulting in growth arrest (Sherr and Roberts, 1995) . p27 Kip1 (p27) is a recently cloned cdk inhibitor which functions as a tumour suppressor mainly by inactivating the cyclin E/cdk2 complex (Polyak et al., 1994a) . We previously reported the expression of cyclins and cdks in proliferating cells of the normal endometrium, and we found that the expression of these molecules were suppressed in the secretory phase . However, little information was obtained regarding negative regulators of the cell cycle which could be involved in the growth inhibition of the endometrium in the secretory phase. In the present study, therefore, to further elucidate the growth regulatory mechanism of the endometrium, the expression of p27 was investigated immunohistochemically and compared with those of Ki-67, cyclin E, cdk2 and progesterone receptors. In addition, to clarify the relationship between the p27 expression and progestational status, we examined the expression of p27 in endometrial tissues from patients with endometrial hyperplasia, both before and after treatment with medroxyprogesterone acetate (MPA); this was found to be a useful in-vivo study for evaluating the effect of progesterone on endometrial tissues.
Materials and methods

Histological materials
Normal endometrial tissue specimens (n ϭ 49) were obtained from 49 women (aged 35-45 years), all of whom had a previous history of pregnancy. The tissue was extirpated at the time of hysterectomy, following the diagnosis of leiomyoma or carcinoma in situ of the uterine cervix. Seven tissue specimens were obtained by curettage from seven patients with endometrial hyperplasia (aged 43-55 years). After the histological diagnoses were made, each of the patients received 400 mg/day of MPA treatment orally for 8-12 weeks. After the treatment, each patient underwent endometrial curettage or hysterectomy to obtain the endometrial specimens. The tissue was used with the approval of the Ethical Committee of Shinshu University, Japan, after obtaining written consent from the patients. Each specimen was immediately fixed in 10% phosphate-buffered formalin for 24 h and embedded in paraffin. Serial sections of 3 µm thickness were made and provided for haematoxylin and eosin (HE) staining and immunostaining. Histological diagnosis and endometrial dating (Noyes et al., 1950) were performed on an HE-stained slide. Of the 49 endometrial tissue specimens, 20 were in the proliferative phase (days 6-14), 12 in the early secretory phase (days 15-21), nine in the mid-secretory phase (days 22-24) and eight in the late secretory phase (days 25-28). The histological diagnosis of all seven endometrial hyperplasia patients was simple hyperplasia without atypia.
Immunohistochemistry
Indirect immunostaining was performed using antibodies against p27 (C-19), cyclin E (HE11) and cdk2 (M2), which were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Antibodies for Ki-67 (MIB-1) and progesterone receptors (PR10A) were purchased from Immunotech (Marseilles, France). Each immunohistochemical staining was performed by the avidin-biotin-peroxidase complex method using a Histofine SAB-PO detector kit (Nichirei Co., Tokyo, Japan). Briefly, after deparaffinization in xylene and rehydration through graded alcohols, each section was treated by microwaving in 0.01 M citrate buffer (pH 6.0) for 15 min. Endogenous peroxidase activity was blocked by 0.03% hydrogen peroxide in methylalcohol for 30 min. Then, 10% normal rabbit (for mouse primary antibodies) or goat serum (for rabbit primary antibodies) was applied to avoid non-specific reactivities. The sections were then incubated with specific primary antibodies [diluted 1: 500 by phosphate-buffered saline (PBS)/bovine serum albumin (BSA) for anti-p27 and cdk2 antibodies, 1:100 for other antibodies] or control non-immunized mouse or rabbit serum at 4°C overnight. After washing with PBS, biotinylated anti-mouse or rabbit immunoglobulin G (IgG) was applied for 30 min at room temperature. After washing with PBS, peroxidase-conjugated streptavidin solution was then applied for 30 min and visualized by 0.05% 3Ј-3Ј diaminobenzidine (DAB). Light counterstaining was performed with haematoxylin.
Interpretation of immunohistochemical staining
The specific staining of p27, cyclin E, cdk2, progesterone receptors and Ki-67 was identified as brown-coloured products in the nucleus and/or cytoplasm. All of the control slides yielded negative staining. The positive staining was evaluated by the percentage of the positive cells among 1000 cells in each section, and is described as the mean percentage of positive cells Ϯ SD in each histological group. In groups where positive cells existed but the mean number of the positive cells was Ͻ0.1%, the result is described as trace (tr). The staining intensity showed variation ranging from weak to strong staining, and cells with weak intensity or more were regarded as positive. The statistical analysis of the immunostaining of each agent in the normal endometria was performed by the Mann-Whitney test (Statview system, Macintosh) for the comparison of the positive ratio in each histological group in the normal endometria. P Ͻ 0.05 was considered to be significant. The paired t-test was used for the comparison of the positive ratio before and after the MPA treatment. The results of the immunostaining for cyclin E, cdk2, progesterone receptors and Ki-67 in the normal endometrium are given in our previous study , but in the present study, the results for cyclin E and cdk2 are cited to describe the correlation between p27 and the cdk2/cyclin E complex. The progesterone receptors and Ki-67 results are also cited to describe the involvement of p27 in the growth inhibition of endometria mediated by a progesterone milieu.
Western blotting
To confirm the antigenic specificity of the antibodies used in the immunostaining, and to obtain a quantitative evaluation of the p27 expression, we performed Western blotting. Four normal endometrial tissue specimens (two specimens each obtained at the proliferative and secretory phases) from the functionalis were homogenized and lysed in 0.5 ml of cell lysis buffer consisting of 50 mM Tris-HCl (pH 8.0), 0.25 M NaCl, 0.5% NP-40, 1 mM phenylmethylsulphonyl fluoride (PMSF; Sigma Chemical Co., St. Louis, MO, USA), 1 µg/ ml aprotinin (Boehringer Mannheim Co, Indianapolis, IN, USA), 1 µg/ml leupeptin (Boehringer Mannheim), and 20 µg/ml TPCK (Boehringer Mannheim). The lysates were centrifuged at 13 000 g for 20 min at 4°C, and the supernatants were stored at -70°C. The extracts equivalent to 30 µg of total protein were separated by sodium dodecyl sulphate (SDS) polyacrylamide gels (10% acrylamide), followed by the equilibration of the gel in transfer buffer consisting of 20% methanol, 192 mM glycine, and 25 mM Tris (pH 8.0) for 3 h. The proteins were then transferred to supported nitrocellulose membranes (Amersham, Bucks, UK) by applying 2400 V-180 min with a plate electrode apparatus (Semi Dry Blotter II; Ken En Tec, Copenhagen, Denmark). The filters were blocked for 1 h in Trisbuffered saline (TBST) consisting of 0.2 M NaCl, 0.2% Tween-20, and 10 mM Tris (pH 7.4), containing 5% non-fat dry milk and 0.02% NaN 3 . Subsequently, the filters were incubated with antibodies against p27 (Santa Cruz Biotechnology, C-19) and β-actin (for the internal standard, AC-15, Biomakor, Rehovot, Israel) (each diluted 1:500) in TBST containing 5% milk, and then the filters were incubated in anti-rabbit IgG (1:1,000; Amersham) in TBST containing 2% milk. The filters were washed several times with TBST after each step. The bound antibody was detected with an enhanced chemi-luminescence (ECL) system (Amersham).
Results
Immunostaining of the normal endometrium
Glandular cells
Expression of p27: Positive staining of p27 was observed in the nucleus and in the cytoplasm of glandular cells. The number of p27-positive cells in the nucleus as well as in the cytoplasm was low in the proliferative phase (Table I, Figure 1a ,b, Figure 2 ) but markedly increased in the secretory phase, with the highest positive rate of nuclear staining in the mid-proliferative phase (positive rate: 91.3 Ϯ 5.2% in the basalis, Table I, Figure 1c and d, Figure 2 ). Though the majority of the cells were positive for p27 in the mid-to late secretory phase, the intensity of the staining showed heterogeneity, i.e. strongly stained sites were intermingled with weakly stained sites. Correlation of p27 with other staining: The number of cells positively stained for Ki-67 was increased in the proliferative phase and decreased in the secretory phase , the pattern of which was in clear contrast to that of p27 (Table I, Figure 2 ). The expression of cyclin E in the nucleus was focally observed throughout the menstrual cycle with the highest positive rate in the mid-secretory phase (Table I, Figures 2, 3a) , and the cyclin E-positive cells were often positive for cdk2 (Figure 3b , Shiozawa et al., 1996) . In the comparison of p27 with cyclin E/cdk2, there was no topographical correlation between p27 and cyclinE/cdk2 in the proliferative phase. In the secretory phase, however, the Immunostaining of p27 in the functionalis (a) and basalis (b) of the proliferative phase, functionalis of the early secretory phase (c) and mid-secretory phase (d). In the proliferative phase, the glandular cells were almost all negative for p27 (a and b) and the stromal cells in the basalis showed strong staining (b). In the secretory phase, the glandular cells showed diffuse positive staining in both the nucleus and the cytoplasm, and the stromal cells showed focally positive staining (c and d, original magnification ϫ175). Table I . Percentage (Ϯ SD) of glandular cells that stained positive for p27, Ki-67, cyclin E, cdk2, and progesterone receptors (PR). (Data on Ki-67, cyclin E, cdk2 and progesterone receptor are taken from Shiozawa et al., 1996) Proliferative phase Secretory phase Sites stained (n ϭ 20) Early (n ϭ 12) Mid (n ϭ 9) Late (n ϭ 8) distribution of the cyclin E/cdk2-positive cells were included in p27-positive sites. In addition, the staining intensity of the p27-positive cells with positive cyclin E/cdk2 staining tended to be stronger than that of the p27-positive cells without cyclin E/cdk2 staining (Figure 3c ). The positive ratio of progesterone receptors of the glandular cells was~98% in the proliferative phase, and it was down-regulated in the secretory phase (Table I , Figure 2 , Shiozawa et al., 1996) . The positive ratio of p27 in the nucleus was higher than that of progesterone receptors, especially in the mid-and late secretory phases. and Ki-67 in the nucleus. The expression of p27 was constant throughout the menstrual cycle, and was more abundant in the basalis than in the functionalis. Conversely, Ki-67 was expressed mainly in the functionalis. B ϭ basalis; F ϭ functionalis.
Stromal cells
In the functionalis, a small number of p27-positive cells were observed throughout the menstrual cycle, with a slight increase in the late secretory phase (Table II, Figure 4 ). In contrast, there was consistently strong nuclear and cytoplasmic staining for p27 in the basalis throughout the menstrual cycle (Table II, Figures 1b, Figure 4 ). The expressions of Ki-67, progesterone receptors, cyclin E and cdk2 in the stromal cells are cited in Table II . In comparison with these factors, Ki-67-positive stromal cells were found more frequently in the functionalis than in the basalis. (Table II , Figure 4 ) This distribution pattern inversely correlated with that of p27. However, no apparent correlation between p27 and progesterone receptors, cyclin E or cdk2 was observed in the stromal cells.
902
Figure 5. Western blotting for p27 of normal endometria. Lanes 1 and 2; proliferative phase, lanes 3 and 4; secretory phase. All four samples showed a single band with a molecular weight of~27 kDa, and the two samples from the secretory phase showed stronger bands than those of the proliferative phase. β-actin was used as an internal control. Figure 6 . Immunostaining of p27 on endometrial hyperplasia before (a) and after (b) the medroxyprogesterone acetate (MPA) treatment. Before the treatment, the expression of p27 was negligible (a). After the treatment, most of the glandular cells were strongly positive for p27 (original magnification ϫ115). 
Western blotting of normal endometrium
Western blots of two samples from the proliferative and the secretory phases of normal endometrium showed single bands with the molecular weight of~27 kDa for p27 ( Figure 5) . However, the two samples of the secretory phase showed a stronger signal compared with that of the proliferative phase.
Immunostaining of the endometrial hyperplasia
Glandular cells
As described in Table III and Figures 6 and 7 , the expression of p27 in the nucleus as well as in the cytoplasm of the hyperplastic epithelia was low (positive ratio: 3.3 Ϯ 1.5 in the nucleus), and the results of the staining were similar to those of the normal epithelia. After the MPA treatment, all seven cases showed atrophic changes. The positive ratio of p27 in the glandular cells after the MPA treatment was significantly increased (P Ͻ 0.001). Conversely, the expressions of Ki-67 and progesterone receptors were significantly decreased after the treatment (Ki-67; P ϭ 0.006, progesterone receptors; P Ͻ 0.001). The positive ratio of cyclin E and cdk2 did not show any significant change after the treatment.
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Stromal cells
The positive ratio of p27 (nucleus) in the stromal cells of the endometrial hyperplasia was 75.1 Ϯ 10.8 (Table III, Figure 6a ), similar to that in the normal endometrium. After the MPA treatment, stromal cells showed decidual changes. Unlike the glandular cells, the difference in the positive ratio for both cytoplasmic and nuclear p27 in stromal cells before and after the MPA treatment was not significant; there was also no significant difference in the positive ratios of Ki-67, progesterone receptors, cyclin E and cdk2 before and after the treatment (Table III) .
Discussion
p27 was originally cloned from transforming growth factor-β (TGF-β)-mediated G 1 -arrested cells (Polyak et al., 1994b) . p27 associates with the cyclin E-cdk2 complex, and inhibits pRb phosphorylation by the cyclin E-cdk2 complex (Polyak et al., 1994a) . The forced overexpression of p27 obstructs cell entry into the S phase (Polyak et al., 1994a, Toyoshima and Hunter, 1994) , and mice lacking p27 exhibit multiorgan hyperplasia (Fero et al., 1996; Kiyokawa et al., 1996; Nakayama et al., 1996) . Thus, p27 is a negative regulator of the G 1 phase of the cell cycle and is regarded as a tumour suppressor. Concerning the subcellular localization of p27, one group of investigators reported the immunoreactivity of p27 to be exclusively nuclear (Fero et al., 1996) , while another group reported both nuclear and cytoplasmic staining (Loda et al., 1997) . In the present study, positive staining of p27 was observed in both the nucleus and cytoplasm. Though the significance of the subcellular localization of p27 is not fully understood, nuclear staining seems to be of importance, since the catalytic partner of cyclin E-cdk2 complexes such as pRb is located primarily in the nucleus (Mittnacht and Weinberg, 1991) . The present immunostaining of the normal endometrium demonstrated a marked increase of p27 expression in the secretory phase in which cell growth was arrested. This staining pattern showed a clear contrast to that of Ki-67, which recognizes proliferating cells (Gerdes et al., 1984) . The results of the immunoblotting also showed an elevated expression of p27 in the secretory-phase endometria, supporting the immunostaining findings. In tissues other than the endometrium, p27 has been found to be present in large amounts in quiescent cells such as the mid-and apical regions of the villi in the intestine. In contrast, p27-positive cells were rare in the proliferating basal region of the villi (Fero et al., 1996) . In this regard, the increased expression of p27 in the glandular cells in the secretory phase is quite reasonable in terms of the growth inhibitory function of p27. Various types of tumour suppressor such as pRb, p53, p21 and p16 have been identified (Sherr and Roberts, 1995) . However, normal endometrium showed only focal or negative staining for pRb, p53 and p21 (unpublished data). The expression of p16 is only weakly positive in glands of the proliferative phase (Shiozawa et al., 1997) . In this context, p27 could be a unique negative regulator of the glandular cells of the endometrium. In our previous study , cyclin E-and cdk2-positive gland cells were also positive for Ki-67 in the proliferative phase. This finding was plausible, since cyclin E and cdk2 are positive regulators of the cell cycle and propel the G 1 phase transition. In the secretory phase, the cyclin Eand cdk2-positive gland cells lacked Ki-67 positivity. Although this finding suggested the G 1 arrest of the cell cycle, its significance remains somewhat enigmatic. However, the present study demonstrated a topographical correlation between cyclin E/cdk2-and p27-positive glandular cells in the secretory phase, suggesting interactions between these molecules. Though p27 was found as a cdk2 inhibitor, p27 is thought to bind to cyclin E-cdk2 complexes rather than cdk2 alone (Polyak et al., 1994a) . Thus, the topographical relationship of the positive sites of p27 with those of cyclin E and cdk2 implies that the growth stimulatory function of cyclin E-cdk2 complex could be counteracted by p27.
The growth of the glandular cells of the normal endometrium is generally thought to be inhibited by progesterone (Strauss and Gurpide, 1991) . The increased expression of p27 in the glandular cells of the secretory phase observed in the present study suggests that the expression of p27 could be mediated by a progesterone-related hormonal environment. The increase in p27 immunoreactivity associated with a decrease in Ki-67 positivity in the hyperplastic epithelia after the MPA treatment also supports this possibility. In addition, progesterone induces cell differentiation, i. e. glandular cells of normal and hyperplastic endometria show secretory changes induced by progesterone, indicating that the growth inhibition as well as the acquisition of secretory changes of endometrial glands induced by a progesterone milieu are associated with the increased expression of p27. Some studies have advocated that cell differentiation occurs while the cell cycle arrest mediated by tumour suppressors such as p21 and p27 (Halevy et al., 1995; Parker et al., 1995) . The present findings in the glands seem to support their advocacies. Likewise, the growth arrest of HL60 cells by vitamin D3 derivative is associated with cell differentiation as well as an increased p27 expression (Wang et al., 1996) .
The biological effects of progesterone are carried out via progesterone receptors. In the present study, the expression of progesterone receptors in the glands of normal endometrium was nearly 100% in the proliferative phase, and down-regulated in the secretory phase. In the mid-and late secretory phases, the positive ratio of p27 in the glands was higher than that of progesterone receptors. In the endometrial hyperplasia, the hyperplastic glands before the MPA treatment were homogeneously positive for progesterone receptors with faint p27 expression. Conversely, those glands after the treatment were negative for progesterone receptors with elevated p27 expression. Several lines of evidence have revealed that the amount of p27 protein is controlled by post-translational mechanisms rather than transcriptional mechanisms (Pagano et al., 1995; Hengst and Reed, 1996; Loda et al., 1997) . If the expression of p27 mRNA is enhanced by progesterone, the elevated expression of p27 with decreased or negative progesterone receptors observed in the mid-and late secretory phases of the normal endometria as well as in the hyperplastic epithelia after the MPA treatment seems contradictory. Rather, it may be that the elevated expression of p27 is a result of a persistent accumulation of p27 due to a prolonged half-life, possibly caused by progesterone-mediated impaired proteolytic activity.
In the stromal cells, the expression of p27 was constantly observed throughout the menstrual cycle, showing an expression pattern different from that of the glandular cells. This finding may also indicate a growth mechanism of the stromal cells distinct from that of the glandular cells in response to the same hormonal environment, as previously reported in terms of steroid receptors (Amso et al., 1994) , Ki-67 (Pickarts et al., 1990) , proliferating cell nuclear antigen (Li et al., 1993) and cyclin/cdk . It is noteworthy that the stromal cells in the basalis showed strong nuclear as well as cytoplasmic staining compared to that in the functionalis throughout the menstrual cycle. In contrast, Ki-67-positive stromal cells were more often observed in the functionalis than in the basalis, and the Ki-67 staining pattern showed a clear contrast to that of p27. This finding indicated the active p27 Kip1 in endometrium growth potential of the functionalis. In the proliferative phase, this seems plausible, since glandular cells also proliferate. In the secretory phase, the continuous growth of the stromal cells may be an advantage in setting the stage for decidualization and future pregnancy. A consistent and strong expression of p27 in the basalis with low labelling of Ki-67 was observed. The glandular as well as stromal cells in the basalis are considered to possess reserve cell-like characteristics, since the cells in this layer escape from the menstrual shedding, and the basalis provides cells to the upper layer in the following menstrual cycle. Thus, the elevated p27 activity in the basalis may be involved in avoiding the excessive growth of the stromal cells.
Collectively, the present study indicates the involvement of p27 in the growth control of the endometrium. Especially, in the glandular cells, progesterone induced p27 may act as a 'switching' molecule changing proliferation to differentiation. Endometrial glands need to cease proliferation as well as acquiring secretory activity for nidation. Such a function of the endometrium has been clinically predicted only by endometrial dating. However, the present data suggest the possibility that the immunohistochemical examination of the p27 might be an additional tool to evaluate the functional status of the endometrium, e.g. loss of p27 expression in the secretory-phase endometria might indirectly imply functional abnormalities.
